| Line item | 2025-11-30 FY | 2024-12-01 FY | 2023-11-26 FY | 2022-11-27 FY | 2021-11-28 FY |
|---|---|---|---|---|---|
| Revenue | $6.28B | $6.36B | $6.18B | $6.17B | $5.76B |
| Cost of Revenue | $2.40B | $2.54B | $2.66B | $2.62B | $2.42B |
| Gross Profit | $3.88B | $3.82B | $3.52B | $3.55B | $3.35B |
| Operating Expenses | – | – | – | – | $407.65M |
| R&D | – | – | – | – | – |
| SG&A | $3.17B | $3.25B | $3.07B | $2.89B | $2.65B |
| Operating Income | $677.60M | $264.10M | $353.30M | $646.50M | $686.21M |
| Interest Expense | – | – | $45.90M | $25.70M | $72.90M |
| Tax Expense | $132.00M | $8.40M | $15.60M | $80.50M | $26.70M |
| Net Income | $578.10M | $210.60M | $249.60M | $569.10M | $553.54M |
| EPS (basic) | 1.4600 | 0.5300 | 0.6300 | 1.4300 | 1.3800 |
| EPS (diluted) | 1.4500 | 0.5200 | 0.6200 | 1.4100 | 1.3500 |
| Shares (diluted) | $399.75M | $402.37M | $401.72M | $403.84M | $409.78M |